Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Tumors Characterized by Genetic Alterations in Anaplastic Lymphoma Kinase (ALK) × ceritinib × 1 year × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 4 Neuroblastoma 2 Neoplasms 2 Lung Neoplasms 2 Sarcoma 1 Neoplasm Metastasis 1 Melanoma 1 Lymphoma, Large-Cell, Anaplastic 1 Granuloma, Plasma Cell 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡